Coagulation disorders in congenital heart disease
KN McMillan, J Kramer, CM Takemoto… - Critical Heart Disease in …, 2019 - Elsevier
This chapter will review the process of normal coagulation in infants and children, examine
the various tests of the clotting mechanism, review the alterations of hemostasis in …
the various tests of the clotting mechanism, review the alterations of hemostasis in …
Management of intraoperative anticoagulation in patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery
A Koster, B Pötzsch, K Madlener - Heparin-induced …, 2007 - taylorfrancis.com
Immediate cessation of, and avoidance of reexposure to, heparin are important principles
underlying the management of patients with immune-mediated heparin-induced …
underlying the management of patients with immune-mediated heparin-induced …
[HTML][HTML] Venous thrombosis and thromboembolism (VTE) in children: Treatment, prevention, and outcome
M Albisetti, AKC Chan - 2019 - medilib.ir
INTRODUCTION—Venous thromboembolism (VTE; which includes venous thrombosis
and/or pulmonary embolism [PE]) is increasingly recognized in the pediatric population as a …
and/or pulmonary embolism [PE]) is increasingly recognized in the pediatric population as a …
Heparin-induced thrombocytopenia in infants after heart surgery
JN Abdillah, Q Hu, X Chen, X Chen… - The Thoracic and …, 2019 - thieme-connect.com
Background Heparin-induced thrombocytopenia (HIT) in infants is a rare disorder, and the
diagnosis and management of HIT still remains challenging. Argatroban is a synthetic direct …
diagnosis and management of HIT still remains challenging. Argatroban is a synthetic direct …
[PDF][PDF] ¿ Cuál es la actitud frente a la trombocitopenia inducida por heparina?
P Solari, M Bosch - Medicina clínica, 2008 - academia.edu
Recibido el 23-11-2007; aceptado para su publicación el 3-1-2008. nes tromboembólicas
(un 10-14% con argatrobán frente al 25% en el grupo control), pero no en la mortalidad ni la …
(un 10-14% con argatrobán frente al 25% en el grupo control), pero no en la mortalidad ni la …
Neonatal thrombosis: Management and outcome
KA Chan, MD Bhatt, JA Garcia-Prats - 2022-04-11)[2023-01-20]. https://www … - uptodate.com
This topic focuses on thrombotic events occurring outside of the central nervous system.
Thrombosis involving the central nervous system (ie, neonatal stroke) is reviewed in detail …
Thrombosis involving the central nervous system (ie, neonatal stroke) is reviewed in detail …
Disorders of Hemostasis
R Huang - The Perioperative Medicine Consult Handbook, 2015 - Springer
Disorders of Hemostasis | SpringerLink Skip to main content Advertisement SpringerLink
Account Menu Find a journal Publish with us Track your research Search Cart Book cover …
Account Menu Find a journal Publish with us Track your research Search Cart Book cover …
[引用][C] Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease
EACLC Jean, GV Rodriguez - 2021
Acquired Thrombocytopenias
PE Davenport, MC Sola-Visner - … : Pathogenesis, Diagnosis, and …, 2021 - books.google.com
In this chapter, we will focus exclusively on acquired thrombocytopenias that present in the
neonatal period. We will discuss the mechanisms underlying some of the most common …
neonatal period. We will discuss the mechanisms underlying some of the most common …
Pediatric bleeding disorders
Y Diab, MF Guerrera - Biochemical and Molecular Basis of Pediatric …, 2021 - Elsevier
Diseases that result in an increased risk of excessive bleeding or altered hemostasis are
commonly seen during childhood. These range from common inherited conditions such as …
commonly seen during childhood. These range from common inherited conditions such as …